Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/41860
Title: 6-[(2S,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-5-fluoropyrimidine-4-carbaldehyde
Author: Sousa, Joana L. C.
Albuquerque, Hélio M. T.
Silva, Artur M. S.
Keywords: Voriconazole
Late-stage functionalization
Hydroxymethylation
Photoredox reaction
Oxidation
NMR spectroscopy
Issue Date: Mar-2023
Publisher: MDPI
Abstract: Voriconazole (VN) is an antifungal drug indicated for the treatment of several fungal infections. Due to its side effects, some works involving late-stage functionalization of VN have been reported in the literature. Here, we disclose a new VN derivative, the 6-[(2S,3R)-3-(2,4-difluorophenyl)- 3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-5-fluoropyrimidine-4-carbaldehyde (VNCHO). This compound results from the photoredox-catalyzed hydroxymethylation of VN, affording a hydroxymethylated derivative (VN-CH2OH), followed by oxidation of the former CH2OH group. VN-CHO was obtained in good yield (70% yield) and its structure was unveiled by 1D (1H and 13C) and 2D (HSQC and HMBC) NMR techniques. The introduction of a formyl group in VN structure creates a very promising site for further functionalization in a molecule which originally does not have many active sites.
Peer review: yes
URI: http://hdl.handle.net/10773/41860
DOI: 10.3390/M1603
Appears in Collections:DQ - Artigos
REQUIMTE - Artigos

Files in This Item:
File Description SizeFormat 
Molbank 2023, 2023, M1603.pdf1.12 MBAdobe PDFView/Open


FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.